Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
2.
Ocul Immunol Inflamm ; 15(1): 27-9, 2007.
Article in English | MEDLINE | ID: mdl-17365803

ABSTRACT

PURPOSE: To evaluate the treatment of subfoveal and juxtafoveal choroidal neovascularization (CNV) using verteporfin photodynamic therapy (vPDT) in patients affected by punctate inner choroidopathy (PIC). METHODS: A chart review of 8 patients with CNV associated with PIC treated with vPDT was done. RESULTS: The 8 patients (8 eyes) included 4 men and 4 women with a mean age of 30.9 years. Six of them presented juxtafoveal CNVs, and two had subfoveal CNVs, at presentation. Mean follow-up time was 22.7 months. The VA improved in five eyes, and three eyes declined. One patient developed a new CNV a few days after vPDT, and one had multiple CNVs at presentation. Two of the 3 patients with longer follow-up period presented late recurrences. CONCLUSIONS: vPDT is a beneficial resource in stabilizing and also improving VA in PIC patients affected with subfoveal and juxtafoveal CNV, although one third of the patients retain poor visual acuity.


Subject(s)
Choroidal Neovascularization/drug therapy , Choroiditis/complications , Fovea Centralis/pathology , Photochemotherapy/methods , Photosensitizing Agents/therapeutic use , Porphyrins/therapeutic use , Adult , Choroidal Neovascularization/complications , Choroiditis/pathology , Female , Fluorescein Angiography , Follow-Up Studies , Fundus Oculi , Humans , Male , Middle Aged , Retrospective Studies , Treatment Outcome , Verteporfin , Visual Acuity
SELECTION OF CITATIONS
SEARCH DETAIL
...